○Koji Izutsu1, Hideki Goto2, Daisuke Ennishi3, Yuko Mishima4, Shinichi Makita1, Koji Kato5, Miyoko Hanaya6, Satoshi Hirano6, Kazuya Narushima6, Takanori Teshima2, Hirokazu Nagai7, Kenichi Ishizawa8 (1.National Cancer Center Hospital, 2.Department of Hematology, Hokkaido University Faculty of Medicine, 3.Department of Hematology and Oncology, Okayama University Hospital, 4.Department of Hematology Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, 5.Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, 6.Kyowa Kirin Co., Ltd., 7.Department of Hematology, National Hospital Organization Nagoya Medical Center, 8.Department of Third Internal Medicine, Division of Hematology and Cell Therapy, Yamagata University Faculty of Medicine)
Session information
Mini-Oral Session
[MO12] Mini-Oral Session 12 Hematologic Malignancies 2(Lymphoid)
【E】
Thu. Feb 17, 2022 8:30 AM - 9:20 AM Room 9 (Swan, 1F, Kyoto International Conference Center)
Chair:Kenji Ishitsuka(Department of Hematology and Rheumatology, Kagoshima University),Yasushi Takamatsu(Division of Medical Oncology, Hematology and Infectious Diseases, Department of Internal medicine, Fukuoka University)
○Kim M. Linton1, BjÖRn Engelbrekt Wahlin2, Sirpa Leppä3, Franck Morschhauser4, Brian Elliott5, Tracy Liu5, Mariana Cota Stirner6, Aqeel Abbas5, Lorenzo Falchi7 (1.The Christie NHS Foundation Trust and Manchester Cancer Research Centre, Manchester, UK, 2.Karolinska Institutet, Stockholm, Sweden, 3.Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland, 4.University of Lille, CHU Lille, Lille, France, 5.Genmab, Princeton, NJ, USA, 6.AbbVie, North Chicago, IL, USA, 7.Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA)
○Anthony Mato1, Jacob Haaber Christensen2, Hans Herluf Bentzen3, Carsten Utoft Niemann4, Martin Hutchings4, Jenny Chen5, Daniela Hoehn5, Marcia Rios5, Tammy Palenski6, Tommy Li5, Arnon P. Kater7 (1.Memorial Sloan Kettering Cancer Center, Chronic Lymphocytic Leukemia Program, New York, NY, USA, 2.Odense University Hospital, Odense, Denmark;, 3.Aarhus University Hospital, Aarhus, Denmark, 4.Rigshospitalet, Copenhagen, Denmark, 5.Genmab, Princeton, NJ, USA, 6.AbbVie, North Chicago, IL, USA, 7.Amsterdam UMC, Cancer Center Amsterdam, University of Amsterdam, Netherlands)
○Hidehito Fukushima, Matsuda Kensuke, Honda Akira, Hiroaki Maki, Kazuki Taoka, Yosuke Masamoto, Mineo Kurokawa (Department of Hematology and Oncology, Tokyo University Hospital)
○Yutaka Shimazu1, Shohei Mizuno2, Shin-Ichi Fuchida3, Kazuhito Suziki4, Nobuhiro Tsukada5, Akira Hanagaishi6, Mitsuhiro Itagaki7, Keisuke Kataoka8, Shinichi Kako9, Emiko Sakaida10, Satoshi Yoshioka11, Shinsuke Iida12, Noriko Doki13, Tatsuo Oyake14, Tatsuo Ichinohe15, Yoshinobu Kanda16, Yoshiko Astuta17,18, Hiroyuki Takamatsu19 (1.Department of Hematology, Kyoto University Hospital, 2.Department of Internal Medicine, Aichi Medical University School of Medicine, 3.Department of Hematology, JCHO Kyoto Kuramaguchi Medical Center, 4.Department of Clinical Oncology / Hematology, the Jikei University Kashiwa Hospital, 5.日本赤十字社医療センター 血液内科, 6.Department of Hematology, National Center for Global Health and Medicine, 7.Department of Hematology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, 8.Division of Hematology, Department of Medicine, Keio University School of Medicine, 9.Division of Hematology, Jichi Medical University Saitama Medical Center, 10.Department of Hematology, Chiba University Hospital, 11.Department of Hematology, Kobe City Medical Center General Hospital, 12.Division of Hematology & Oncology, Nagoya City University Hospital, 13.Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 14.Division of Hematology and Oncology, Iwate Medical University, 15.Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 16.Division of Hematology, Department of Medicine, Jichi Medical University, 17.Japanese Data Center for Hematopoietic Cell Transplantation, 18.Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, 19.Department of Hematology, Kanazawa University)
○Fenia Tandy1, Audrey Hadisurya1, Marlyn Suciningtias1, Celine Chrystelle1, Andree Kurniawan2 (1.Faculty of Medicine, Pelita Harapan University, 2.Department of Internal Medicine, Faculty of Medicine, Pelita Harapan University)